The Government Council has authorized the expenditure of 4.55 million to acquire 7,000 doses of Hesper zoster vaccines and hematimetry, coagulation and cytometry reagents for the Clinical Analysis service of the San Pedro Hospital. The vaccines aim to protect population groups that present certain risk conditions from the age of 18, as well as those who turn 65 and 80 years of age.
The Government Council has authorized the expenditure of 4.55 million euros to acquire vaccines that protect risk groups from the age of 18 and over, as well as those who turn 65 and 80, from herpes zoster, and to guarantee the supply of hematimetry, coagulation and cytometry reagents for the laboratories of the San Pedro University Hospital.
Herpes zoster (HZ) is a very prevalent disease, with a higher incidence after the age of 50 and in women, increasing with age and, considerably, with the presence of certain risk conditions. It has a low mortality, but an increase in incidence is expected due to the aging of the population and the increasing number of people with comorbidities (when two or more disorders or diseases occur in the same person, at the same time or one after the other). and immunosuppression.
Since 2023, and following the recommendations of the Ministry of Health, immunization has been expanded to both risk groups over 18 years of age (hematopoietic stem cell transplant, solid organ transplant, HIV, treatment with jak kinase (JAK) inhibitors) , malignant hemopathies, solid tumors, history of two or more episodes of herpes zoster), as well as the population cohorts that are turning 65 years old and those turning 80 years old, until vaccination is completed in this age range.
The objective of the contract, budgeted at 875,420 euros, is the acquisition of more than 7,000 doses to ensure the protection of the target population until December 31 of this year. The tender form will be through a negotiated procedure without advertising, given that the only inactivated vaccine against herpes zoster authorized and marketed in Spain is Shingrix (HZ/su), from the GSK company, as indicated in the Agency’s certificate. Spanish Medicines and Health Products. This vaccine is the only one that can be administered to immunocompromised people, the main risk group for shingles.
On the other hand, the regional Executive has given light to the Rioja Health Service (SERIS) to allocate 3,669,841.61 euros to supply the laboratories of the San Pedro University Hospital with hematimetry, coagulation and cytometry reagents, which are a fundamental piece in the Clinical Analysis service, offering a variety of specialized tests to diagnose and monitor disorders related to the blood and immune system.
The contract, which is being called divided into 4 lots and will be awarded through an open procedure, includes the transfer and installation of the equipment necessary to manage the samples, as well as to obtain the results in the most automated way possible.
The contract will be executed between September 1 and December 31, 2027. It is extendable for periods equal to or less than 12 months up to a maximum total of 60 consecutive months. Its financing is broken down into the following annual payments:
2024: 366,984.17 euros
2025: 1,100,952.48 euros
2026: 1,100,952.48 euros
2026: 1,100,952.48 euros
